ClinicalTrials.govpublic full text
A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
acute myeloid leukemia, as1411, aml, relapsed, refractory, aptamer, nucleolin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 807620
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.